Literature DB >> 304776

Lymphocyte subpopulations in chronic liver disease.

I G McFarlane, A L Eddleston, R Williams.   

Abstract

Entities:  

Mesh:

Year:  1977        PMID: 304776      PMCID: PMC1541164     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


× No keyword cloud information.
  10 in total

1.  The active E rosette test: correlation with delayed cutaneous hypersensitivity.

Authors:  P J Felsburg; R Edelman; R H Bilman
Journal:  J Immunol       Date:  1976-04       Impact factor: 5.422

2.  Proceedings: Primary and secondary immune responses to phiX 174 in patients with primary biliary cirrhosis and chronic active hepatitis.

Authors:  H C Thomas; R Holden; J Verrier-Jones; D Peacock
Journal:  Gut       Date:  1975-10       Impact factor: 23.059

3.  T and B lymphocytes in patients with chronic active hepatitis (CAH).

Authors:  M Colombo; S J Vernace; F Paronetto
Journal:  Clin Exp Immunol       Date:  1977-10       Impact factor: 4.330

4.  T and B lymphocytes in acute and chronic hepatitis.

Authors:  R J DeHoratius; R G Strickland; R C Williams
Journal:  Clin Immunol Immunopathol       Date:  1974-04

5.  Peripheral blood T and B cells in chronic inflammatory bowel disease.

Authors:  R G Strickland; S Korsmeyer; R D Soltis; I D Wilson; R C Williams
Journal:  Gastroenterology       Date:  1974-10       Impact factor: 22.682

6.  Enhanced binding of neuraminidase-treated sheep erythrocytes to human T lymphocytes.

Authors:  M S Weiner; C Bianco; V Nussenzweig
Journal:  Blood       Date:  1973-12       Impact factor: 22.113

7.  Letter: T cells, B cells, and HL-A8 in chronic active hepatitis.

Authors:  P Tolentino; A Astaldi
Journal:  Lancet       Date:  1975-03-22       Impact factor: 79.321

8.  Peripheral blood lymphocyte populations in chronic liver disease.

Authors:  H C Thomas; M Freni; J Sanchez-Tapias; D de Villiers; S Jain; S Sherlock
Journal:  Clin Exp Immunol       Date:  1976-11       Impact factor: 4.330

9.  Peripheral blood lymphocyte cell surface markers during the course of systemic lupus erythematosus.

Authors:  R P Messner; F D Lindström; R C Williams
Journal:  J Clin Invest       Date:  1973-12       Impact factor: 14.808

10.  Potentiation of T-cell mediated immunity by levamisole.

Authors:  G Renoux; M Renoux; M N Teller; S McMahon; J M Guillaumin
Journal:  Clin Exp Immunol       Date:  1976-08       Impact factor: 4.330

  10 in total
  3 in total

1.  Decreased suppressor T cell activity in patients with hepatic cirrhosis (HC).

Authors:  S Tomino; H Fujiwara; T Kagimoto; H Mitsuya; H Nishimura; S Kishimoto
Journal:  Clin Exp Immunol       Date:  1982-06       Impact factor: 4.330

2.  Immunological evaluation of asymptomatic carriers of hepatitis B virus.

Authors:  Y Levo; D Shouval; R Tur-Kaspa; S Wollner; S Penchas; A Zlotnick; M Eliakim
Journal:  Clin Exp Immunol       Date:  1981-04       Impact factor: 4.330

3.  Evaluation of serum rosette inhibitory factors in chronic liver disease.

Authors:  D Zauli; F B Bianchi; M Fusconi; C Crespi; E Pisi
Journal:  Clin Exp Immunol       Date:  1983-07       Impact factor: 4.330

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.